Key Discovery Milestones With active concentrations in the nanomolar range (10 M) and a safety margin 300-fold above therapeutic doses, GHK-Cu combines potent biological activity with an excellent safety profile established through decades of clinical use and research studies published in peer-reviewed journals like PubMed
One injection, four lanes of recovery
Those numbers are significant
It's also been studied for its potential to improve the outcomes for patients undergoing chemotherapy, as it may reduce some of the oxidative side effects associated with these treatments
requires thiamine pyrophosphate [TPP]: Measurement of red blood cell transketolase activity is a convenient bioassay to test for TPP deficiency
During the last 3 h of culture, 10% (v/v) of cell counting kit-8 (CCK-8) reagent was added to each well of the cultured TSPCs (Dojindo Molecular Technologies, Kumamoto, Japan)